Reyon Pharmaceutical Co. Ltd. (102460)
Market Closed
15 Jun, 06:30
KRX SM KRX SM Primary ₩
9,920. 00
+20
+0.202%
₩
221.93B Market Cap
- P/E Ratio
600% Div Yield
66,256 Volume
- Eps
₩ 9,900
Previous Close Want to track 102460 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Reyon Pharmaceutical Co. Ltd. (102460) Statistics
Valuation metrics
Market Cap 221.93B
Enterprise value 396.46B
Trailing P/E (ttm) -4.45
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) 1.25
Price/Book (mrq) 0.87
Enterprise Value/Revenue 2.73
Enterprise Value/EBITDA -159.13
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 70.26K
Average volume (90 days) 82.63K
Price summary
52-Week low 9,100
52-Week high 14,430
Beta -
50-Day moving average 10,900
200-Day moving average 10,912.18
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 29 Dec 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.28%
Operating margin -0.23%
Operational effectiveness
Return on assets -0.09%
Return on equity -0.18%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 7,917.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2,223.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 237.22
Total debt (mrq) -
Total Debt/Equity (mrq) 1.05
Current ratio (mrq) 0.52%
Book value per share (mrq) 11,427.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
